Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells

British Journal of Cancer

Volumn 101, Issue 12, 2009, Pages 2023-2029

  Yokota, N ^a,b   Koizume, S ^a   Miyagi, E ^b   Hirahara, F ^b   Nakamura, Y ^a   Kikuchi, K ^a   Ruf, W ^a   Sakuma, Y ^a   Tsuchiya, E ^a   Miyagi, Y ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Coagulation factor VII; Hypoxia; Ovarian cancer; TF positive microparticle; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

ARTICLE; CANCER CELL; CANCER PATIENT; CELL SURFACE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOSIS; WESTERN BLOTTING;

CELL HYPOXIA; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; FACTOR VII; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; THROMBOPLASTIN; VENOUS THROMBOEMBOLISM;

EID: 71649104953     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605406     Document Type: Article

References (28)

1. Amin C, Mackman N, Key NS (2008) Microparticles and cancer. Pathophysiol Haemost Thromb 36: 177-183
2. Amirkhosravi A, Meyer T, Warnes G, Amaya M, Malik Z, Biggerstaff JP, Siddiqui FA, Sherman P, Francis JL (1998) Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor. Thromb Haemost 80: 598-602
3. Chew HK, Wun T, Harvey DJ, Zhou H, White RH (2007) Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 25: 70-76
4. Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, Baker CH, Francis JL (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6: 1517-1524
5. Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A (2000) Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res 6: 480-487
6. Dewhirst MW, Cao Y, Moeller B (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425-437
7. Furie B, Furie BC (1988) The molecular basis of blood coagulation. Cell 53: 505-518
8. Han LY, Landen Jr CN, Kamat AA, Lopez A, Bender DP, Mueller P, Schmandt R, Gershenson DM, Sood AK (2006) Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. J Clin Oncol 24: 755-761
9. Hron G, Kollars M, Weber H, Sagaster V, Quehenberger P, Eichinger S, Kyrle PA, Weltermann A (2007) Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97: 119-123
10. Iodice S, Gandini S, Lohr M, Lowenfels AB, Maisonneuve P (2008) Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost 6: 781-788
11. Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB (2007) Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13: 2870-2875
12. Kim KS, Sengupta S, Berk M, Kwak YG, Escobar PF, Belinson J, Mok SC, Xu Y (2006) Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res 66: 7983-7990
13. Koizume S, Jin MS, Miyagi E, Hirahara F, Nakamura Y, Piao JH, Asai A, Yoshida A, Tsuchiya E, Ruf W, Miyagi Y (2006) Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res 66: 9453-9460
14. Koizume S, Yokota N, Miyagi E, Hirahara F, Tsuchiya E, Miyagi Y (2008) Heterogeneity in binding and gene-expression regulation by HIF-2alpha. Biochem Biophys Res Commun 371: 251-255
15. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC (1996) Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 148: 1567-1576
16. Lopez JA, del Conde I, Shrimpton CN (2005) Receptors, rafts, and microvesicles in thrombosis and inflammation. J Thromb Haemost 3: 1737-1744
17. Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembo-lism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 89: 640-664
18. Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH (2007) Venous thromboembolism in ovarian cancer. Gynecol Oncol 105: 784-790
19. Rong Y, Hu F, Huang R, Mackman N, Horowitz JM, Jensen RL, Durden DL, Van Meir EG, Brat DJ (2006) Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 66: 7067-7074
20. Rong Y, Post DE, Pieper RO, Durden DL, Van Meir EG, Brat DJ (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 65: 1406-1413
21. Ruf W (2007) Tissue factor and PAR signaling in tumor progression. Thromb Res 120(Suppl 2): S7-S12
22. Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S, Minami R, Matsumoto K, Tanaka YO, Tsunoda H, Homma S, Yoshikawa H (2007) High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer 97: 1053-1057
23. Tateo S, Mereu L, Salamano S, Klersy C, Barone M, Spyropoulos AC, Piovella F (2005) Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 99: 119-125
24. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5: 520-527
25. Uno K, Homma S, Satoh T, Nakanishi K, Abe D, Matsumoto K, Oki A, Tsunoda H, Yamaguchi I, Nagasawa T, Yoshikawa H, Aonuma K (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96: 290-295
26. Varki A (2007) Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723-1729
27. Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W, Stern D (1998) Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95: 8298-8303
28. Yu JL, Rak JW (2004) Shedding of tissue factor (TF)-containing micro-particles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2: 2065-2067